News + Filings Holdings
All
13F
13D/G
Other
|
|
Cormorant Global Healthcare Master Fund, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.4% stake in Praxis Precision Medicines, Inc. |
| 06/08/2023 |
SC 13D
| Cormorant Global Healthcare Master Fund, LP reports a 6.1% stake in GreenLight Biosciences Holdings, PBC |
| 05/01/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 9.3% stake in EyePoint Pharmaceuticals, Inc. |
| 04/03/2023 |
SC 13D/A
| Cormorant Global Healthcare Master Fund, LP reports a 10.2% stake in Biomea Fusion, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 4.7% stake in Edgewise Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 10% stake in Rain Oncology Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.2% stake in Edgewise Therapeutics, Inc. |
| 05/18/2021 |
SC 13G
| Cormorant Global Healthcare Master Fund, LP reports a 5.3% stake in Edgewise Therapeutics, Inc. |
| 05/07/2021 |
SC 13G
| Cormorant Global Healthcare Master Fund, LP reports a 10% stake in Rain Therapeutics Inc. |
| 04/30/2021 |
SC 13D
| Cormorant Global Healthcare Master Fund, LP reports a 11% stake in Biomea Fusion, Inc. |
| 11/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/17/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|